{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:35:24Z","timestamp":1759336524347,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ejmech.2023.115117","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T12:10:36Z","timestamp":1673611836000},"page":"115117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Synthesis and evaluation of anti-yellow fever virus activity of new 6-aryl-3-R-amino-1,2,4-triazin-5(4H)-ones"],"prefix":"10.1016","volume":"248","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8576-4568","authenticated-orcid":false,"given":"Yevhenii","family":"Novodvorskyi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Lesyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Komarov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry","family":"Lega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iryna","family":"Zhuravel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleh","family":"Moskalenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volodymyr","family":"Sukhoveev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatolii","family":"Demchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115117_bib1","first-page":"97","article-title":"Mosquito-borne diseases","volume":"39","author":"Tolle","year":"2009","journal-title":"Curr. Probl. Pediatr. Adolesc. Health Care"},{"key":"10.1016\/j.ejmech.2023.115117_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00827-18","article-title":"Yellow fever virus: diagnostics for a persistent arboviral threat","volume":"56","author":"Waggoner","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ejmech.2023.115117_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.antiviral.2012.12.002","article-title":"Experimental therapies for yellow fever","volume":"97","author":"Julander","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115117_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2008.08.004","article-title":"Molecular targets for flavivirus drug discovery","volume":"81","author":"Sampath","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115117_bib5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2007.10.009","article-title":"Treatment of yellow fever","volume":"78","author":"Monath","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115117_bib6","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00705-022-05494-8","article-title":"Animal venoms as a source of antiviral peptides active against arboviruses: a systematic review","volume":"167","author":"Lima","year":"2022","journal-title":"Arch. Virol."},{"key":"10.1016\/j.ejmech.2023.115117_bib7","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/v14061226","article-title":"Mosquito-borne flaviviruses and current therapeutic advances","volume":"14","author":"Qian","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2023.115117_bib8","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1021\/jm1013538","article-title":"Design, synthesis, and biological evaluation of thiazoles targeting flavivirus envelope proteins","volume":"54","author":"Mayhoub","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115117_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115117_bib10","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2023.115117_bib11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s11515-010-0660-y","article-title":"Flavivirus RNA cap methyltransferase: structure, function, and inhibition","volume":"5","author":"Liu","year":"2010","journal-title":"Front. Biol."},{"key":"10.1016\/j.ejmech.2023.115117_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","article-title":"T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections","volume":"82","author":"Furuta","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115117_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.antiviral.2006.08.008","article-title":"Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model","volume":"73","author":"Julander","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115117_bib14","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.bmcl.2009.01.031","article-title":"A heterocyclic molecule with significant activity against dengue virus","volume":"19","author":"Nair","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.115117_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12985-017-0761-1","article-title":"Inhibitors compounds of the flavivirus replication process","volume":"14","author":"Garc\u00eda","year":"2017","journal-title":"Virol. J."},{"key":"10.1016\/j.ejmech.2023.115117_bib16","article-title":"Natural compounds against flaviviral infections","volume":"8","author":"Abubakr","year":"2013","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.ejmech.2023.115117_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0166-3542(03)00175-X","article-title":"In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain)","volume":"60","author":"Ono","year":"2003","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115117_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-3542(02)00185-7","article-title":"Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses","volume":"58","author":"Crance","year":"2003","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115117_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3923\/ijv.2012.285.287","article-title":"Squalamine: may be an effective viral control","volume":"8","author":"Ozaslan","year":"2012","journal-title":"Int. J. Virol."},{"key":"10.1016\/j.ejmech.2023.115117_bib20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.virol.2008.11.003","article-title":"A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor","volume":"384","author":"Zou","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.ejmech.2023.115117_bib21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.toxicon.2011.05.021","article-title":"Crotoxin and phospholipases A2 from Crotalus durissus terrificus showed antiviral activity against dengue and yellow fever viruses","volume":"59","author":"Muller","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.ejmech.2023.115117_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/np50055a001","article-title":"Didemnins and tunichlorin: novel natural products from the marine tunicate trididemnum solidum","volume":"51","author":"Rinehart","year":"1988","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2023.115117_bib23","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1128\/AAC.00686-10","article-title":"A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro","volume":"54","author":"Kaptein","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115117_bib24","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/cmdc.202000464","article-title":"Broad-spectrum flavivirus inhibitors: a medicinal chemistry point of view","volume":"15","author":"Felicetti","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2023.115117_bib25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.antiviral.2009.09.007","article-title":"In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses","volume":"84","author":"Kampmann","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115117_bib26","doi-asserted-by":"crossref","first-page":"10774","DOI":"10.1128\/JVI.01253-16","article-title":"A novel benzodiazepine compound inhibits yellow fever virus infection by specifically targeting NS4B protein","volume":"90","author":"Guo","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2023.115117_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.01429-12","article-title":"A novel inhibitor of dengue virus replication that targets the capsid protein","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115117_bib28","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1128\/AAC.02251-12","article-title":"Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115117_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.antiviral.2010.03.004","article-title":"Efficacy of 2\u2032-C-methylcytidine against yellow fever virus in cell culture and in a hamster model","volume":"86","author":"Julander","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115117_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.antiviral.2017.12.018","article-title":"Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease","volume":"150","author":"Li","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115117_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007072","article-title":"Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo","volume":"13","author":"de Freitas","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2023.115117_bib32","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.cell.2015.10.046","article-title":"Defining Hsp70 subnetworks in dengue virus replication reveals key vulnerability in flavivirus infection","volume":"163","author":"Taguwa","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2023.115117_bib33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/17460441.2022.2084529","article-title":"An overview on small molecules acting as broad-spectrum agents for yellow fever infection","volume":"17","author":"Desantis","year":"2022","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.115117_bib34","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archderm.1977.01640090149047","article-title":"Azaribine, homocystinemia, and thrombosis","volume":"113","author":"Shupack","year":"1977","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ejmech.2023.115117_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/009286150103500134","article-title":"Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets-1960 to 1999","volume":"35","author":"Fung","year":"2001","journal-title":"Drug Inf. J. : DIJ \/ Drug Info. Ass."},{"key":"10.1016\/j.ejmech.2023.115117_bib36","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2174\/1389557521666210805105146","article-title":"Dengue virus entry\/fusion inhibition by small bioactive molecules: a critical review","volume":"22","author":"Naresh","year":"2022","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115117_bib37","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1248\/yakushi1947.80.8_1068","article-title":"Synthesis of as-triazine derivatives and their antiviral effect","volume":"80","author":"Nakata","year":"1960","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.ejmech.2023.115117_bib38","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1248\/cpb.11.1551","article-title":"Syntheses and antiviral activity of 3-Thioxo-6-aryl-3, 4-dihydro-as-triazin-5 (2H)-one and 6-Aryl-as-triazine-3, 5 (2H, 4H)-dione","volume":"11","author":"Watanabe","year":"1963","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2023.115117_bib39","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1039\/C9RA00618D","article-title":"Novel chalcone derivatives containing a 1,2,4-triazine moiety: design, synthesis, antibacterial and antiviral activities","volume":"9","author":"Tang","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2023.115117_bib40","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s11172-008-0130-8","article-title":"Azolo[5,1-c]-1,2,4-triazines as a new class of antiviral compounds","volume":"57","author":"Rusinov","year":"2008","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.ejmech.2023.115117_bib41","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1128\/AAC.01186-09","article-title":"Antiviral properties, metabolism, and pharmacokinetics of a novel azolo-1,2,4-triazine-derived inhibitor of influenza A and B virus replication","volume":"54","author":"Karpenko","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115117_bib42","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/BF00767030","article-title":"Synthesis and antiviral activity of 6-nitro-7-oxo-4,7-dihydroazolo-[5,1-c] [1,2,4]-triazines","volume":"24","author":"Rusinov","year":"1990","journal-title":"Pharmaceut. Chem. J."},{"key":"10.1016\/j.ejmech.2023.115117_bib43","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10593-021-02925-3","article-title":"3-Cyanoazolo[5,1-c][1,2,4]triazines: synthesis and antiviral activity","volume":"57","author":"Sapozhnikova","year":"2021","journal-title":"Chem. Heterocycl. Compd."},{"key":"10.1016\/j.ejmech.2023.115117_bib44","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.bmcl.2015.04.006","article-title":"N-((1,3-Diphenyl-1H-pyrazol-4-yl)methyl)anilines: a novel class of anti-RSV agents","volume":"25","author":"Fioravanti","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.115117_bib45","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1016\/j.bmc.2008.08.028","article-title":"Antimicrobial and cytotoxic arylazoenamines. Part III: antiviral activity of selected classes of arylazoenamines","volume":"16","author":"Tonelli","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115117_bib46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0166-3542(02)00013-X","article-title":"Identification of active antiviral compounds against a New York isolate of West Nile virus","volume":"55","author":"Morrey","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115117_bib47","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/cber.19841170322","article-title":"Synthesis and structures of as-triazinoquinazolines, I","volume":"117","author":"Abdel-Hady","year":"1984","journal-title":"Chem. Ber."},{"key":"10.1016\/j.ejmech.2023.115117_bib48","article-title":"Synthesis of some 1,2,4-triazine derivatives with potential biological activity","volume":"43","author":"Eid","year":"1988","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejmech.2023.115117_bib50","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1021\/ci500467k","article-title":"iLOGP: a simple, robust, and efficient description of n-octanol\/water partition coefficient for drug design using the GB\/SA approach","volume":"54","author":"Daina","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2023.115117_bib51","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115117_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2023.115117_bib53","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115117_bib54","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/jm015507e","article-title":"Simple selection criteria for drug-like chemical matter","volume":"44","author":"Muegge","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115117_bib55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J. Combin. Chem."},{"key":"10.1016\/j.ejmech.2023.115117_bib56","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115117_bib57","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1021\/jm0492002","article-title":"A bioavailability score","volume":"48","author":"Martin","year":"2005","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423000326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423000326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:49:00Z","timestamp":1759330140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423000326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":56,"alternative-id":["S0223523423000326"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115117","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of anti-yellow fever virus activity of new 6-aryl-3-R-amino-1,2,4-triazin-5(4H)-ones","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115117"}}